# Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors

> **NCT01234922** · PHASE2 · TERMINATED · sponsor: **Wake Forest University Health Sciences** · enrollment: 6 (actual)

## Conditions studied

- Hypertension
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** lisinopril
- **DRUG:** losartan potassium
- **OTHER:** laboratory biomarker analysis
- **DRUG:** benazepril hydrochloride
- **DRUG:** ramipril

## Key facts

- **NCT ID:** NCT01234922
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-02
- **Primary completion:** 2013-12
- **Final completion:** 2014-04
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** slow accrual
- **Last updated:** 2018-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01234922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01234922, "Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01234922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*